These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26021573)

  • 1. [Partial 3ß-hydroxysteroid dehydrogenase type 2 deficiency: Diagnosis of a novel mutation after positive newborn screening for 21-hydroxylase deficiency].
    Bahíllo-Curieses MP; Loidi Fernández de Trocóniz L; del Cañizo López A; Martínez-Sopena MJ
    Med Clin (Barc); 2016 Jan; 146(2):92-3. PubMed ID: 26021573
    [No Abstract]   [Full Text] [Related]  

  • 2. High 17-hydroxyprogesterone level in newborn screening test for congenital adrenal hyperplasia.
    Levy-Shraga Y; Pinhas-Hamiel O
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26912766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening].
    Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B
    Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3β-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency.
    Jeandron DD; Sahakitrungruang T
    Horm Res Paediatr; 2012; 77(5):334-8. PubMed ID: 22343390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Virilizing Congenital Adrenal Hyperplasia in a Female Patient with a Novel HSD3B2 Mutation.
    Probst-Scheidegger U; Udhane SS; l'Allemand D; Flück CE; Camats N
    Sex Dev; 2016; 10(4):200-204. PubMed ID: 27626911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.
    Lekarev O; Tafuri K; Lane AH; Zhu G; Nakamoto JM; Buller-Burckle AM; Wilson TA; New MI
    J Perinatol; 2013 Jan; 33(1):76-8. PubMed ID: 23269230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3β-hydroxysteroid dehydrogenase type II deficiency on newborn screening test.
    Araújo VG; Oliveira RS; Gameleira KP; Cruz CB; Lofrano-Porto A
    Arq Bras Endocrinol Metabol; 2014 Aug; 58(6):650-5. PubMed ID: 25211449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.
    Lee CT; Tung YC; Hsiao PH; Lee JS; Tsai WY
    J Formos Med Assoc; 2010 Feb; 109(2):148-55. PubMed ID: 20206839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Homozygous Frameshift Mutation in the HSD3B2 Gene in an Apparently Nonconsanguineous Italian Family.
    Bizzarri C; Massimi A; Federici L; Cualbu A; Loche S; Bellincampi L; Bernardini S; Cappa M; Porzio O
    Horm Res Paediatr; 2016; 86(1):53-61. PubMed ID: 27082427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygosis for CYP21A2 mutation considered as 21-hydroxylase deficiency in neonatal screening.
    Soardi FC; Lemos-Marini SH; Coeli FB; Maturana VG; Silva MD; Bernardi RD; Justo GZ; de-Mello MP
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1388-92. PubMed ID: 19169499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3β-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts].
    Huang Y; Zheng J; Xie T; Xiao Q; Lu S; Li X; Cheng J; Chen L; Liu L
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):948-51. PubMed ID: 25619355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency.
    Cara JF; Moshang T; Bongiovanni AM; Marx BS
    N Engl J Med; 1985 Sep; 313(10):618-21. PubMed ID: 3160950
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico structural, functional and pathogenicity evaluation of a novel mutation: an overview of HSD3B2 gene mutations.
    Rabbani B; Mahdieh N; Haghi Ashtiani MT; Setoodeh A; Rabbani A
    Gene; 2012 Jul; 503(2):215-21. PubMed ID: 22579964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Müssig K; Kaltenbach S; Maser-Gluth C; Hartmann MF; Wudy SA; Horger M; Gallwitz B; Raue F; Häring HU; Schulze E
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):208-14. PubMed ID: 16705555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and diagnosis of congenital adrenal hyperplasia in Basilicata (Italy).
    Cordova RA; Vignola G
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():103. PubMed ID: 11400742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.